[1]
van Riet, B.H. et al. 2025. Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma. Acta Oncologica. 64, (Jan. 2025), 69–77. DOI:https://doi.org/10.2340/1651-226X.2025.42333.